REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Dr.Max 15 S.R.O. (Slovakia)

Main Activities: Pharmacies and Drug Stores | Department Stores
Secondary Activities: General Merchandise Stores, including Warehouse Clubs and Supercenters | Other Publishers | Other Nondepository Credit Intermediation | Lessors of Other Real Estate Property | Accounting, Tax Preparation, Bookkeeping, and Payroll Services
Full name: Dr.Max 15 S.R.O. Profile Updated: October 21, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Dr.Max 15 S.R.O. is an enterprise located in Slovakia, with the main office in Kosice. It operates in the Pharmacies and Drug Stores sector. It was established on February 22, 2011. In its most recent financial highlights, the company reported a net sales revenue increase of 49.53% in 2024. During that time, Dr.Max 15 S.R.O.’s total assets grew by 51.33%. In, 2024, the company’s net profit margin decreased by 0.08%.

Headquarters
Moldavska cesta, 8/A
Kosice; Kosicky; Postal Code: 04011

Contact Details: Purchase the Dr.Max 15 S.R.O. report to view the information.

Basic Information
Registered Capital:
Purchase the Dr.Max 15 S.R.O. report to view the information.
Financial Auditors:
Purchase the Dr.Max 15 S.R.O. report to view the information.
Incorporation Date:
February 22, 2011
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Legal Representative
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Dr.Max 15 S.R.O. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
49.53%▲
Total operating revenue
39.07%▲
Operating profit (EBIT)
58.14%▲
EBITDA
102.8%▲
Net Profit (Loss) for the Period
44.46%▲
Total assets
51.33%▲
Total equity
22.37%▲
Operating Profit Margin (ROS)
0.17%▲
Net Profit Margin
-0.08%▼
Return on Equity (ROE)
2.79%▲
Debt to Equity Ratio
-0.77%▼
Quick Ratio
-0.65%▼

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo